United Capital Financial Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-253
Closed -$5K 1132
2022
Q3
$5K Hold
253
﹤0.01% 1080
2022
Q2
$13K Buy
253
+43
+20% +$3.2K ﹤0.01% 1112
2022
Q1
$30K Buy
210
+20
+11% +$2.92K ﹤0.01% 1147
2021
Q4
$32K Hold
190
﹤0.01% 1188
2021
Q3
$95K Buy
190
+5
+3% +$2.32K ﹤0.01% 1172
2021
Q2
$93K Hold
185
﹤0.01% 1194
2021
Q1
$94K Buy
185
+2
+1% +$1.03K ﹤0.01% 1163
2020
Q4
$87K Hold
183
﹤0.01% 1157
2020
Q3
$53K Buy
183
+7
+4% +$1.74K ﹤0.01% 1130
2020
Q2
$34K Buy
176
+12
+7% +$2K ﹤0.01% 1170
2020
Q1
$20K Buy
164
+5
+3% +$905 ﹤0.01% 1166
2019
Q4
$28K Buy
159
+4
+3% +$517 ﹤0.01% 1350
2019
Q3
$23K Buy
155
+41
+36% +$5.46K ﹤0.01% 1283
2019
Q2
$13K Hold
114
﹤0.01% 1455
2019
Q1
$19K Hold
114
﹤0.01% 1342
2018
Q4
$13K Buy
114
+26
+30% +$3.99K ﹤0.01% 1277
2018
Q3
$13K Buy
88
+11
+14% +$4.6K ﹤0.01% 1325
2018
Q2
$51K Buy
77
+9
+13% +$6.73K ﹤0.01% 1285
2018
Q1
$69K Buy
68
+6
+10% +$5.02K ﹤0.01% 1280
2017
Q4
$75K Buy
62
+11
+22% +$5.17K ﹤0.01% 1283
2017
Q3
$9K Buy
+51
New +$8.07K ﹤0.01% 1305

Other funds holding AMPE

United Capital Financial Advisors's AMPE Position: Q4 2022 in Review

United Capital Financial Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 253 shares — an estimated $5K sold.

United Capital Financial Advisors first reported a position in AMPE in Q3 2017 and held it in 21 quarters. The position peaked at $95K in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • United Capital Financial Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • United Capital Financial Advisors sold 253 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $5K.
  • United Capital Financial Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q3 2017 and held it in 21 quarters.
  • United Capital Financial Advisors's Ampio Pharmaceuticals Inc. position peaked at $95K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on United Capital Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.